LFAC Leapfrog management outlines targeted crosssector expansion plans following its latest quarterly earnings release Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Is Destra Multi DMA stock a logical buy right now